Navigation Links
Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
Date:8/12/2008

MOUNTAIN VIEW, Calif., Aug. 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, announced today that it has entered into a co-marketing agreement with InTouch Health to facilitate the advancement of stroke care in the U.S. Concentric Medical and InTouch Health will work with hospitals to create centers of excellence for treating acute ischemic stroke, developing comprehensive programs that offer patients the broadest range of options in acute stroke intervention.

Concentric Medical provides Merci Retrieval Systems(TM), as well as tools, resources and physician training to help hospitals provide state-of-the-art care for patients suffering from ischemic stroke. InTouch Health provides Remote Presence technology, which is a next generation telemedicine solution combining the power of robotics, wireless, and the Internet to achieve full physician coverage for patients that present to the hospital with acute stroke symptoms.

Maria Sainz, President and CEO of Concentric Medical said, "Concentric Medical is excited to team with InTouch Health to bring about real change in the way hospitals address the care of acute ischemic stroke and extends the reach of their growing stroke networks. Prompt access to physicians who can provide all interventional options including Concentric's Merci Retrieval System is a critical component in the effective treatment of this disease."

Yulun Wang, Ph.D., Chairman and CEO of InTouch Technologies said, "I am very pleased to announce this agreement with Concentric Medical. Together we have an opportunity to give stroke patients everywhere a better chance of survival by delivering faster and more efficient access to state-of-the-art stroke expertise and care through our Remote Presence telestroke networks."

About Concentric Medical

Concentric Medical is located in Mountain View, California, and was founded in August 1999. The company m
'/>"/>

SOURCE Concentric Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...KJAVIK, Iceland, November 24 /PRNewswire-FirstCall...nnounced the approval of all of its,"first day" mo...t of Delaware,(the "Bankruptcy Court"). deCODE las... Chapter 11 of the United States Bankruptcy Code w...sued by the Bankruptcy Court allow the company to ...
(Date:11/24/2009)...Newswire/ -- Blue Marble Energy Corp. announced to...ment Authority (OPDA) were recently awarded $2 mil...talization Board (CERB) in a private/public partne...chemical biorefinery in Lincoln County, WA. ,...velopment of our biorefinery and bring over 70 gre...
(Date:11/24/2009)...r 24 Shire plc (LSE: SHP...ceutical company, today,announced that it has subm...elaglucerase alfa, the company,s enzyme replacemen... 1 Gaucher disease. This is the third marketing,ap...mitted, with previous,submissions in the United St...
(Date:11/24/2009)...m Connects Customers with Partners Validated to Pr...ek Products , Ottawa, ON ...ing provider of products for biological sample col...unced its new global partner program. The program ...partner community and is designed to help partners...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ear and fourth quarter 2007 preservation services ...pectively, to approximately $93.7 million for the...TLANTA, Jan. 10 CryoLife, Inc. (NYSE: CRY ),a bi...ompany, announced,today that preservation services...$93.7 million compared to $81.1 million in 2006, a...
...esearchers designing and building new microelectro...est method developed at the National Institute of ...echanical property of such systems: elasticity. Th... films not only for MEMS devices but also for semi... 1727, scientists and engineers have used Youngs m...
...meros Corporation announced today that,it has file... Exchange,Commission relating to the proposed init... All shares of the common stock to be sold in the ...Securities Inc. will be acting as,the sole book-ru...e acting,as the co- lead manager, and Leerink Swan...
Other Biology Technology:CryoLife Announces Record Preservation Services and Product Revenues for 2007 2CryoLife Announces Record Preservation Services and Product Revenues for 2007 3CryoLife Announces Record Preservation Services and Product Revenues for 2007 4NIST develops test method for key micromechanical property 2Omeros Corporation Files Registration Statement for Proposed Initial Public Offering 2
(Date:11/25/2009)... Soil is the linchpin of the environment, where at... that, many students see soil as "just dirt" a pl... educators are challenged with the task of helping...portance of soil in the environment. , A collab...teachers at University of Nebraska-Lincoln, Oregon...
(Date:11/24/2009)...een prescribed by traditional healers in Brazil to...ach pain to fever and flu. , Now for the first ti...able to scientifically prove the pain relieving pr...razilian mint. , Testing this ancient South Ameri...ela Rocha was able to show that when prepared as a...
(Date:11/24/2009)...labby arteries from collapsing have been true life... longer needed -- once the arteries are strengthen...ad no choice but to leave them in place. , Prof....ent of Biomedical Engineering has developed a new ...here they,re needed, then dissolves. , "Our new ...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Eliminate the Blues with Color Therapy 54599 1Eliminate the Blues with Color Therapy 54599 2Eliminate the Blues with Color Therapy 54599 3New nanolaser key to future optical computers and technologies 13581 1New nanolaser key to future optical computers and technologies 13581 2New nanolaser key to future optical computers and technologies 13581 3Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 1Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 2Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 3Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 4
...Foundation, through its Autism Research Initiative...h the Rutgers University Cell and DNA Repository (...r autism studies. The samples will be collected fr...d. , The Simons Simplex Collection, as this proj...r a new and different line of research into the ge...
...September 04, 2007 - The term "biotechnology" elic...ar and hostility. Alan McHughen from the Universit... at large the current state public knowledge of bi...cy and the role of the media. How is coexistence d...agricultural biotech only big companies or also t...
...h showing that dog-walking in bushland significant...support to bans against the practice in sensitive ...uments and debate about the ecological impacts of ...d because experimental evidence has been lacking. ...e dogs as predators and avoid dog-walking areas is...
Other Biology News:Rutgers Genetics receives $7.8 million for autism research 2Rutgers Genetics receives $7.8 million for autism research 3How the public perceives biotech 2A dog in the hand scares birds in the bush 2
Sheep Anti-Human CATHEPSIN G Polyclonal Antibody, Unconjugated from AbD Serotec
Flammable Chemical Cabinets, Justrite Model 25042 from South Coast Enterprises
Mouse Anti-Bovine CD335 Monoclonal Antibody, ALEXA FLUOR 488 Conjugated, Clone AKS1 from AbD Serotec
Sheep Anti-Human Aminopeptidase P1 / XPNPEP1 Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: